Your browser doesn't support javascript.
loading
Alloimmunity But Not Viral Immunity Promotes Allograft Loss in a Mouse Model of Polyomavirus-Associated Allograft Injury.
Kim, Steven C; Wang, Jun; Dong, Ying; Mathews, David V; Albrecht, Joshua A; Breeden, Cynthia P; Farris, Alton B; Lukacher, Aron E; Ford, Mandy L; Newell, Kenneth A; Adams, Andrew B.
Afiliación
  • Kim SC; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
  • Wang J; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
  • Dong Y; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
  • Mathews DV; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
  • Albrecht JA; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
  • Breeden CP; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
  • Farris AB; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
  • Lukacher AE; Penn State College of Medicine, Department of Microbiology and Immunology, Hershey, PA.
  • Ford ML; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
  • Newell KA; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
  • Adams AB; Emory University School of Medicine, Emory Transplant Center, Atlanta, GA.
Transplant Direct ; 3(6): e161, 2017 Jun.
Article en En | MEDLINE | ID: mdl-28620645
ABSTRACT

BACKGROUND:

The interplay between viral infection and alloimmunity is known to influence the fate of transplanted organs. Clarifying how local virus-associated inflammation/injury and antiviral immunity can alter host alloimmune responses in transplantation remains a critical question.

METHODS:

We used a mouse model of polyomavirus (PyV) infection and kidney transplantation to investigate the roles of direct viral pathology, the antiviral immune response, and alloimmunity in the pathogenesis of PyV-associated allograft injury. We have previously shown that an effective primary T cell response is required in PyV-associated graft injury.

RESULTS:

Here we show that the transfer of primed antidonor, but not antiviral, T cells results in PyV-associated allograft injury. In further studies, we use a surrogate minor antigen model (ovalbumin) and show that only antidonor specific T cells and not antiviral specific T cells are sufficient to mediate injury. Lastly, we demonstrate that local but not systemic virus-mediated inflammation and injury within the graft itself are required.

CONCLUSIONS:

These data suggest that in this mouse model, the predominant mechanism of allograft injury in PyV-associated injury is due to an augmented alloimmune T cell response driven by virus-induced inflammation/injury within the graft. These studies highlight the important interplay between viral infection and alloimmunity in a model system.

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Risk_factors_studies Idioma: En Revista: Transplant Direct Año: 2017 Tipo del documento: Article País de afiliación: Gabón

Texto completo: 1 Colección: 01-internacional Tipo de estudio: Risk_factors_studies Idioma: En Revista: Transplant Direct Año: 2017 Tipo del documento: Article País de afiliación: Gabón